PRME Stock Price - Prime Medicine, Inc. logo

PRME Stock Price

Prime Medicine, Inc.

$3.84
-$0.35(-8.35%)
60
Overall
55
Value
83
Tech
42
Quality
How is this score calculated?
Market Cap
$698.58M
Volume
4.49M
52W Range
$2.67 - $5.91
Target Price
$7.11

PRME stock price is $3.84 (-8.35% on the day), giving Prime Medicine, Inc. a market cap of $698.58M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

PRME Stock Overview

Price
$3.84
Previous close
$4.19
Open
$4.25
Market cap
$698.58M
52-week range
$2.67 - $5.91
1-year price target
$7.11
Exchange
Nasdaq
MarketXLS Rank
60

About Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

ABCD
1SymbolPriceChangeVol
2PRME$3.84-8.4%4.49M
3
4
5
6

Get Prime Medicine, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.